Category Archives: Northern Westchester Hospital News

Healthy Thanksgiving Recipes from a Hospital Dietitian

Posted on: November 12, 2013

Have a Happy, Healthy Thanksgiving

by Stephanie Perruzza, MS, RD, CDN, Northern Westchester Hospital

ThanksgivingCranberry sauce, loaded mashed potatoes, green been casserole (with French fried onion toppings), creamed spinach…the list goes on for traditional Thanksgiving fare. Oh, and let’s not forget the ever-popular deep fried turkey.  It’s no wonder the phrase “healthy thanksgiving sides” is often uttered: “thanksgiving sides, healthy?”

You don’t have to forfeit flavor when making a side dish in order to make it healthy. Many traditional sides can be modified to decrease calories. Try these below with your family this year: Continue reading

TwitterFacebookShare |

New York Hospital CEO Discusses Planetree Re-Designation

Posted on: July 21, 2013

by Joel Seligman – President & CEO, Northern Westchester Hosptial 

Joel Seligman, CEO Northern Westchester Hospital

It is with great pride that I announce that NWH has again been awarded National Planetree Re-Designation as a Patient-Centered Hospital!

The Planetree Designation Committee was unanimous in its assessment that Northern Westchester Hospital meets “the spirit and intent of the Designation criteria”,  that  re-designation is well-deserved, and that NWH serves as a role model for other hospitals.   Continue reading

Dr. Jerald Wishner Explains How a Progressive Surgical System Robot Improves Colorectal Surgery and More

Posted on: July 12, 2013

NWH Adds Innovative Surgical Robot for Minimally Invasive Surgery

by Jerald Wishner, MD, FACS, FASCRS, Co-Director of the Institute for Robotic and Minimally Invasive Surgery at NWH.

Wishner,(Jerald Wishner, MD)A recent article in MD News chronicles the latest move by NWH to ensure that colorectal surgery and other laparoscopic procedures performed at Northern Westchester Hospital is more precise than even more. Using the da Vinci Surgical System Robot is paramount for NWH surgeons.  This pioneering instrument is proving to be an appreciated top choice for the department, and perhaps a game changer for doctors at NWH in Westchester County. Continue reading

New York Pulmonary Specialist Discusses Asthma

Posted on: June 20, 2013

Are Asthma Attacks Rising With the Temperature This Summer?

By Dr. Harlan Weinberg, Medical Director of Pulmonary Medicine, Northern Westchester Hospital

Asthma If it seems like asthma is on the rise, it is. The Centers for Disease Control and Prevention report that doctors diagnosed 4.3 million more Americans with the condition over the last ten years. Unfortunately, no one really knows why asthma is increasing. In spring and summer, the increase in temperature, pollen, and humidity can make asthma attacks more likely. Luckily, there are plenty of ways to protect yourself or loved ones.

Asthma is characterized by inflammation in the airways. This inflammation can lead to shortness of breath, a tight feeling in the chest, and wheezing. The condition can limit your ability to exercise or partake in activities of daily living. The inflammation can be caused by a number of triggers, such as allergies, dust mites, pollen, infections, certain foods, and environmental factors like pollution or mold. The full list is substantial, which means it may take a while to find a patient’s trigger. Blood tests for allergies can help narrow down the candidates. Patients may also want to keep a journal to jot down the places and times when breathing gets worse. Continue reading

Dr. Jonathan Goldberg Describes 2 New York Clinical Trials for Follicular NHL

Posted on: March 6, 2013

Dr. Jonathan Goldberg, Cancer Center WestchesterFollicular non-Hodgkin’s lymphoma (follicular NHL) is the most common of the indolent (slow growing) non-Hodgkin’s lymphomas, and the second most common form of non-Hodgkin’s lymphomas overall. Low-grade follicular NHL is a slow growing but thus far incurable disease that patients tend to live with for many years.

The major goals of follicular NHL therapy are to reduce lymphoma activity thereby improving disease related symptoms and to prolong complete remissions, while limiting the side effects of therapy wherever possible. Rituximab is a highly targeted, well-tolerated therapy against these lymphomas.  Given either alone or together with chemotherapy, it is the current standard of care for these patients. While using rituximab alone has a much lower potential for side effects, the remission rate is lower at approximately 30 – 50%.

I am the local lead investigator of two clinical trials—HOMER and CALGB 50901—being conducted at Northern Westchester Hospital to study a potential new therapy for follicular NHL. 

Although not yet studied in follicular NHL, ofatumumab has induced remissions in patients with similar conditions resistant to other medications. Continue reading